GLP-1 and GLP-1RAs Glucagon-like peptide-1 (GLP-1) is a 30-amino-acid peptide derived from its precursor, proglucagon, a protein expressed in enteroendocrine cells and cells of the pancreas, as well as in the nucleus of the solitary tract (NTS) in the brainstem
We know that roughly 51% of Americans meet the diagnostic criteria for GLP-1 use, and then on top of that, there are several randomized control trials underway right now looking at how GLP-1s may have a benefit in other diseases, explains Whitney Evans, director of nutrition and scientific affairs at Danone North America
Concerns Mount Over GLP-1 Drugs and Eye Health A commentary by bioenergetic researcher Georgi Dinkov argued that GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro are marketed as safe solutions for diabetes and weight loss, yet mounting evidence shows they worsen conditions they're intended to prevent
Dont let em
If you are struggling with obesity, diabetes, or weight-related health problems, consult an expert to know whether GLP-1 therapy is suitable for you
GLP-1 medications have the potential to provide several key benefits for women with PCOS: Improved Insulin Sensitivity: PCOS is often characterized by insulin resistance, which can contribute to the development of type 2 diabetes
